FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Birgit Pechstein

Research Profile

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Mathias Locher; Hartmut Derendorf
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.
Katharina Erb; Klaus Junge; Birgit Pechstein; Edith Schneider; Hartmut Derendorf; Robert Hermann
Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.
Michael Ludwig; Carola Albano; F Olivennes; Ricardo Felberbaum; Johan Smitz; Olaf Ortmann; Peter Romeis; Georg Niebch; Birgit Pechstein; H Riethmüller-Winzen; Paul Devroey; Klaus Diedrich
Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Birgit Pechstein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Mathias Locher; Hartmut Derendorf
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.
Journal of clinical pharmacology 2003;43(3):243-51.
2002: Katharina Erb; Klaus Junge; Birgit Pechstein; Edith Schneider; Hartmut Derendorf; Robert Hermann
Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.
Journal of clinical pharmacology 2002;42(9):995-1001.
2002: Michael Ludwig; Carola Albano; F Olivennes; Ricardo Felberbaum; Johan Smitz; Olaf Ortmann; Peter Romeis; Georg Niebch; Birgit Pechstein; H Riethmüller-Winzen; Paul Devroey; Klaus Diedrich
Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF.
Archives of gynecology and obstetrics 2002;266(1):12-7.
2001: Katharina Erb; Christine Klipping; Ingrid J M Duijkers; Birgit Pechstein; A Schueler; Robert Hermann
Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.
Fertility and sterility 2001;75(2):316-23.
2000: Nelamangala V Nagaraja; Birgit Pechstein; Katharina Erb; Christine Klipping; Robert Hermann; Georg Niebch; Hartmut Derendorf
Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women.
Clinical pharmacology and therapeutics 2000;68(6):617-25.
2000: Katharina Erb; Birgit Pechstein; A Schueler; J Engel; Robert Hermann
Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
Clinical pharmacology and therapeutics 2000;67(6):660-9.
2000: Birgit Pechstein; Nelamangala V Nagaraja; Robert Hermann; Peter Romeis; Mathias Locher; Hartmut Derendorf
Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers.
Journal of clinical pharmacology 2000;40(3):266-74.